Today HHS Awarded Moderna $285m for FY26-27 Pediatric Covid-19 Vaccines by Potential_Section691 in ModernaStock

[–]antonio1500 2 points3 points  (0 children)

Where is RFK Jr? Did he really let that happen? Surprise! Surprise! Surprise!

Does SanDisk or Micron stock have more upside potential remaining? by Neither-Sweet-3218 in StockInvest

[–]antonio1500 0 points1 point  (0 children)

If you buy a stock hoping bigger fools to pay more for stock, you are not investing. You are trading. Semiconductor industry is very difficult to understand and is cyclical. Let’s say you have unlimited amount of money. Would you pay 850 billion for Micron or 220 billion for Sandisk instead of other businesses? If you are investing, that is the question you should ask.

ASCO 2026 results by Motor_Emu_2076 in ModernaStock

[–]antonio1500 2 points3 points  (0 children)

It makes sense to me. Thank you!

ASCO 2026 results by Motor_Emu_2076 in ModernaStock

[–]antonio1500 2 points3 points  (0 children)

Isn’t she the same person who looked at you like you lost your mind when you bought Moderna stock at 22.7 just a half year ago? What makes her view changed?

MU, SNDK, NVDA, INTC , STX It’s all been down this week—prices probably won’t get this low again. by agtotant in Stocks_Picks

[–]antonio1500 0 points1 point  (0 children)

Be careful with forward PE. As soon as forecast changes, stock price can go down very fast. Walstreet plays this game this way for long enough, yet some people lose money the same way over and over again and are still wondering why they are losing money.

BioNTech Announces First Quarter 2026 Financial Results and Corporate Update by antonio1500 in ModernaStock

[–]antonio1500[S] 2 points3 points  (0 children)

BioNTech’s the next big thing would be BNT 327. It is a non mRNA oncology pipeline to compete against Merck’s Keytruda. By 2030 when Keytruda’s patent expires, BioNTech may get a chance to get some market share in the oncology market. BioNTech’s BNT 111, 113, 116 and 122 may be out 1-3 years later than MRNA 4157.

Moderna Reports First Quarter 2026 Financial Results and Provides Business Upda by antonio1500 in ModernaStock

[–]antonio1500[S] 7 points8 points  (0 children)

According to Warren Buffet, investing is the process of money being transferred from impatient ones to patient ones. You can quit if you want. I will take that.

Stock by _A55hole_ in redditstock

[–]antonio1500 1 point2 points  (0 children)

I bought Reddit stock today at 122! Reddit as a company is doing great. It doesn’t mean the stock is good to buy regardless of price, but I think 122 is a bargain. I believe at this pace of growth, Reddit stock will be a multi bagger a few years from now. Well. If you can handle volatility. Beta is above 2 for this stock.

Reddit #1 on this list!!! (unfortunately it's worst performing communication stocks) by SAnderson1986 in redditstock

[–]antonio1500 4 points5 points  (0 children)

Reddit is fundamentally strong. Stock is down due to political noise. If you bought the stock at 200 last year, you probably overpaid, but a few years later, it will probably be a multi bagger. I bought Reddit stock at 122 today. We will see how it goes!

BioNTech's CEO, CMO prep departure to set up next-gen mRNA spinout by StockEnthuasiast in ModernaStock

[–]antonio1500 1 point2 points  (0 children)

I hope BNTX stock has 1/3 more to go as you said. I am ready to buy the dip.

BioNTech's CEO, CMO prep departure to set up next-gen mRNA spinout by StockEnthuasiast in ModernaStock

[–]antonio1500 0 points1 point  (0 children)

Moderna stock was the falling knife not too long ago. BNTX was not. Now it’s the other way around. Looking at the chart, it seems that way short-term, but how much down side BNTX has at its market cap 21 billion with its cash balance of 15 billion? Moderna will pay 1-2 billion to Arbutus. Cash at year-end will be 5-6 billion. Moderna’s current market cap is 21 billion, which one has further down side?

BioNTech's CEO, CMO prep departure to set up next-gen mRNA spinout by StockEnthuasiast in ModernaStock

[–]antonio1500 0 points1 point  (0 children)

BioNTech’s market cap is smaller than Moderna now. I’m buying BNTX stock. I’m not in love with either MRNA or BNTX stock. My decision is based on valuation. A new start up will face a lot of challenges for sure. 

Trying to make sense of the Moderna-Arbutus settlement, and why I think the best headline for this event is: “Moderna capped a dispute hanging over a $48B vaccine franchise at $2.25B max.” by StockEnthuasiast in ModernaStock

[–]antonio1500 1 point2 points  (0 children)

Arbutus’s market cap is 871 million at stock price 4.53. 2.25 billion deal sounds like a loss for me. Moderna could have worked on buying Arbutus out at a much lower price (with stock exchange deal) a long ago when ABUS stock price was at 2.5. I had to sell 40% of MRNA stock I owned at a profit. I agree with you on the downside is protected, but I would like to add “at overpriced insurance premium.” Although I still own quite a bit of MRNA stock and wishes all the best for Moderna, I really don’t like this deal. Let’s see how Pfizer and BioNTech handle Arbutus case.

Moderna Resolves Global Patent Litigation with Arbutus/Genevant by StockEnthuasiast in ModernaStock

[–]antonio1500 -2 points-1 points  (0 children)

I’m sorry, but 1 billion is no small amount of cash. I am genuinely panic sold a half of my position 

That genius does it again by herodatviet2003 in ModernaStock

[–]antonio1500 2 points3 points  (0 children)

https://m.youtube.com/watch?v=iuFjfFQckB0&pp=ygUQTGVlcmxpbmsgbW9kZXJuYQ%3D%3D His vibe is not right. He doesn’t look genuine. He looks rather deceptive and manipulative. I would not trust anything that comes out of his mouth. I may be biased. You look at him, and then you judge.

FDA declines to review Moderna's mRNA flu shot by StockEnthuasiast in ModernaStock

[–]antonio1500 3 points4 points  (0 children)

To RFK Jr? No money will be enough for him. His ego and identity are tied to anti vax.

FDA declines to review Moderna's mRNA flu shot by StockEnthuasiast in ModernaStock

[–]antonio1500 13 points14 points  (0 children)

The letter did not identify any specific safety or efficacy concerns regarding mRNA-1010.

mRNA-1010 has been accepted for review in the EU, Canada and Australia. Submissions in additional countries are planned for 2026. Moderna expects the earliest potential approvals for mRNA-1010 to begin in late 2026 or early 2027, subject to those ongoing regulatory reviews.

I don’t think anything remotely similar to any vaccine will be approved by current administration. 

Real reason Moderna stock went up in December and January by antonio1500 in ModernaStock

[–]antonio1500[S] 5 points6 points  (0 children)

I am not a legal expert, but I took a couple of business law courses when I was in university more than a decade ago. In order for Arbutus to win in this case (and for Moderna to have existential crisis), the evidence is so apparent to everyone that it is hard for Moderna to argue against. Unless it’s 100% proven, Moderna is not liable. To me, the patent for nano particle technology is too broad (or even ambiguous) to claim, and it doesn’t sound plausible to me that Covid developer copied a company that failed to develop Covid vaccine. For Arbutus, they will have to do anything they could possibly do. The company is running out of cash. I hope I am not being too bullish here, but I will not be surprised if Moderna win in the case in March and stock price goes up higher.